DENALI GROWTH PARTNERS

Thesis

Denali Growth Partners (DGP) is a growth equity firm founded in 2020 and based in Boston, Massachusetts. The firm specializes in providing expansion capital to established private companies, primarily in the United States, with a strategic focus on the healthcare, life sciences, software, technology, and tech-enabled business services sectors. Denali's investment thesis centers on partnering with exceptional founders and capital-efficient businesses, aiming to enhance health outcomes while lowering the cost of care. Denali Growth Partners employs a growth equity strategy, targeting companies that have moved beyond the startup phase and require capital to scale operations, enter new markets, or pursue strategic acquisitions. Denali seeks businesses with proven business models and existing revenue that need capital to accelerate their growth. The firm's geographic scope is primarily North America, with a focus on companies headquartered in the United States. Denali's investment strategy is designed to improve the delivery and consumption of healthcare services. Denali Growth Partners Fund I, a growth equity fund of over $200 million, was raised in 2021. Denali Growth Partners Fund II closed at $400 million in May 2025. As of May 1, 2025, Denali Growth Partners manages over $750 million in regulatory assets under management. While specific check sizes per deal are not publicly disclosed, growth equity investments typically range from several million to tens of millions of dollars, depending on the company's needs and growth stage.

Related lists

• Series C+ AI investors
• Series C+ Healthcare investors
• Series C+ investors based in Boston, MA